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ABSTRACT
Context: Nondisclosure of cancer diagnosis is common in many Eastern countries. Consequently, immigrant families often approach 
oncologists with requests for nondisclosure in Western countries.
Aims: To explore differences in the attitudes and practices of Western‑born and nonWestern born oncologists in Australia when 
faced with a nondisclosure request.
Settings and Design: Using a cross‑sectional design, oncologists were interviewed over the telephone.
Methods: Using the snowball method, 14 Australian (Western = 9, non‑Western = 5) oncologists were recruited. Oncologists 
participated in a semi‑structured interview exploring their experiences of, and response to, a request for nondisclosure, and their 
perceptions of how their cultural background influenced these attitudes and responses.
Analysis: The interviews were transcribed and analyzed using interpretative phenomenological analysis.
Results: Six main themes emerged from the study: (1) Barriers to truthful communication, (2) an ethical and moral dilemma, (3) high 
costs of nondisclosure, (4) cultural influences on interpretation and understanding of requests for nondisclosure, (5) emotional impact 
of bad news on patients, families and oncologists, and (6) truthful disclosure as a gentle balancing act.
Conclusions: All oncologists felt that the family request for nondisclosure was difficult, with many cultural and emotional nuances 
to take into consideration. Some immigrant Australian oncologists who had a similar cultural background as the patient/family, felt 
they could better understand the desire for nondisclosure. Irrespective of their cultural background, all oncologists acknowledged 
that breaking bad news had to be done in a gentle, gradual manner. The study suggests a need to develop a culturally sensitive 
cancer communication model.
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INTRODUCTION
Full disclosure, patient autonomy and informed 
consent are the fulcrum of medical ethics in the 
West.[1‑4] Consequently, Western medical practice 
promotes open and free communication with 
patients such that they are fully aware of their 
illness and treatment, their queries are addressed 
and patients are encouraged and supported to be 
involved in medical decision‑making. However, 
variations in patient‑doctor preferences, especially 
in multicultural societies, suggest a discrepancy 
between doctors’ and patients’ attitudes towards 
cancer disclosure, communication styles and 
medical decision‑making.[5,6] Patients from Eastern 
cultures seeking cancer treatment in Western 
countries may prefer nondirect communication, 
and sometimes nondisclosure.[6] The role of 
family in medical decision‑making is also more 
pronounced and acceptable among patients from 
Eastern cultures,[7,8] with patients sometimes 
expecting the family to supersede them in terms 
of receiving information and being involved in 
decision‑making.[5]
Contrasting to Western medical practice, oncologists 
in Eastern countries comply with this family‑centered 
approach by routinely communicating diagnosis 
and prognosis information to families, allowing 
them to make disclosure and other medical 
decisions for the patient.[9‑11] However, while a 
number of studies have explored oncologists’ 
responses to nondisclosure requests, there is no 
published research that has explored the role of 
oncologists’ own culture on these responses within 
a multicultural Western environment. Therefore, 
the current study explored differences between 
Western and non‑Western‑born oncologists in the 
way they interpreted and dealt with the family 
request for nondisclosure in Australia.
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METHODS
Participants and procedure
Eligible participants were oncologists (medical, surgical, and 
radiation) practicing in Australia. Participants were recruited 
using snowball and purposive sampling. Three E‑mails were 
initially sent by the Medical Oncology Group of Australia (the 
peak representative body for medical oncologists in Australia) 
to their membership, detailing the study and requesting 
interested oncologists to E‑mail the lead researcher.
Following their interview, participants were asked to nominate 
other oncologists, inform them about the study and if they 
were interested, provide them the researcher’s E‑mail address 
to contact. The researcher then contacted these oncologists to 
obtain informed consent. The researcher particularly sought 
to balance the sample with Western and nonWestern‑born 
oncologists. Recruitment continued until informational 
redundancy (saturation of themes) was achieved, with three 
consecutive interviews yielding no new themes.
Semi‑structured interviews with open‑ended questions 
were developed to focus on oncologists’ experiences of a 
request for nondisclosure, how their cultural background 
influenced their attitudes, and how they handled the issue 
of nondisclosure [Table 1]. Interviews were conducted by a 
psychologist trained in qualitative methods, recorded over the 
telephone, and subsequently transcribed and analyzed. Each 
interview took approximately 40 minutes. Ethical approval 
for the study was obtained from the Human Research Ethics 
Committee at the University of Sydney.
Analysis
The study used interpretative phenomenological analysis,[12] a 
qualitative research methodology that is primarily interested in 
understanding a homogenous group of individuals’ subjective 
accounts or perceptions of certain events or experiences they 
commonly experience.[13] Emergent themes based on the 
authors’ interpretations of the recorded interviews were noted 
for each transcript, and characteristic quotes were identified 
to exemplify each theme. Themes were then checked for 
emerging patterns, differences and consistency, similarities 
across participants and the role of specific accounts. From 
these, super‑ordinate themes were iteratively developed, 
which were used as a basis for clustering sub‑ordinate themes 
when analyzing subsequent transcripts. Pseudonyms have 
been used for all quotes. Whole or part quotes presented in the 
text are italicized. Full quotes for each theme and subordinate 
theme are presented in Table 2.
RESULTS
Fourteen oncologists (12 males, 2 females), aged 34‑57 years, 
participated in the study, of whom nine were Western and 
five were non‑Western‑born [Table 3]. Six themes were 
identified.
Barriers to truthful communication
All oncologists commented that there were several barriers to 
truthful communication, when they saw an immigrant patient. 
A family request for nondisclosure was the first and “biggest” 
barrier to truthful communication, which challenged their 
ability to talk honestly to patients at the outset. Oncologists 
observed that family interference was due to many reasons: 
Firstly a belief that a cancer diagnosis was tantamount to a 
death sentence, stemming from immigrancy at an early age, 
which left families without access to the information they 
could understand and marooned them in the medical world 
of their childhood. As a consequence family members feared 
that cancer disclosure could result in poor psychological 
outcomes for the patient, that they may refuse treatment, 
lose hope, die immediately after disclosure or not be able to 
cope with the news.
Five Western‑born oncologists reported that another barrier to 
truthful communication was not sharing a common language 
with the patient, as this led to a “superficial,” nondirect 
relationship with the patient conducted through family or 
professional interpreters. With such patients they often found 
it challenging to understand their level of awareness of their 
illness or desire for additional information. Further, oncologists 
noticed that while patients were comforted by having an 
interpreter who could speak their language, professional 
interpreters were also impersonal, as “it’s not their job to 
be involved in the human interaction”. Consequently, they 
felt distanced from their patients and unable to offer them 
a personalized relationship and emotional support. While 
the family did add value in terms of creating an emotionally 
supportive consultation, five Western oncologists and 
one non‑Western‑born oncologist (Chung) observed that the 
language barrier was made more difficult when families were 
interpreters. They suspected that family members did not 
always translate what they were really saying, thus interfering 
with the doctor‑patient relationship and breeding mistrust in 
the relative as an “unreliable” interpreter.
An ethical and moral dilemma
All participant oncologists recognized that the family’s 
request for nondisclosure posed an ethical and moral dilemma. 
Administering patients “toxic”, “poisonous” and “aggressive” 
medication without them being fully informed of their 
condition and the reason for this treatment, made oncologists 
very “uncomfortable.” The oncologists believed relatives were 
Table 1: Interview topics
Preference for disclosure/nondisclosure with reasons for preference
Barriers or constraints when communicating with patients, role of 
family
How do they go about dealing with the family, role of own cultural 
background
How do they break the bad news to the patient, role of own cultural 
background
Managing of feelings of patient, family and self when breaking bad 
news
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Table 2: Quotes
Super‑ordinate themes Sub‑ordinate themes Quote
Barriers to truthful 
communication
Family interference “…Basically the family members will usually pull us aside before the consultation and 
they will indicate … their preference for nondisclosure of a malignant diagnosis as they 
are concerned that their parents or family member will not be able to cope with the 
diagnosis” (Chris, Malaysia)
Historical pessimism “…The main reason why is that, you know, cancer was basically a commitment to die 
…As soon as they use the word cancer before, people said “Oh they they’re definitely 
going to die”” (Tariq, Iran)
Language barrier “…Even though you try not to speak in scientific or too medical terms I think sometimes 
that their understanding of words. and of how the body works maybe is a barrier and 
then I find it hard to talk.” (Sylvia, UK)
Lack of trust in family as 
interpreter
“….Especially even worse, if the family is being used as the interpreter. So you don’t 
know exactly how much the patient understands and how much they (family) actually 
interpret (what I say)” (Chung, HK)
An ethical and moral 
dilemma
Patient autonomy “…I think that it’s wrong to deny people the opportunity to hear that they’ve got cancer 
or the opportunity to hear that the prognosis might be good or bad or that they may or 
may not be treatment options “ (James, UK)
Desire to respect family’s 
wishes and ensuring 
a straightforward 
consultation to the 
patient
“I’d say to him “Okay I’m going to try and understand where you’re coming form but 
you have to understand where I’m coming from. He needs to know that he’s got cancer 
because otherwise he might understand only that it’s a treatment of death, he’ll get 
more scared you know, he’ll have a tougher time is you know is that what you want?” 
…. say to him you know “Can you‑I’m very happy if you explain that to this patient. You 
know so you are in charge”” (Stan, Australia)
Duty as oncologist to 
patient, not family
“So often I get around it sometimes by saying, “Do you realize that my duty as a carer 
is not to you but it’s to them?”” (Joe, Australia)
High costs of 
nondisclosure
Counter‑productive for 
both family and patient
“….I think nondisclosure often leads to a lot of conflict because …it makes the patient 
much more difficult to manage because the family will have unrealistic expectations 
as well as the patient themselves might have very unrealistic expectations” (Chris, 
Malaysia)
Personal sense of regret “…You may never resolve it; you may never get the chance to…have that discussion. 
Sometimes there’s other relatives…they may never allow you the privacy to do it. 
…they always leave you with a lingering feeling that this could have been done 
better” (Joe, Australia)
Culture influences 
interpretation and 
understanding 
of requests for 
nondisclosure
Own cultures helps 
understand and 
communicate with family
“My culture offers me a very good opportunity to understand what it (cancer) means 
and why they (family) are asking for that (nondisclosure) and… because of that 
understanding I can then speak to them and explain to them about the problems about 
that kind of request” (Surya, Sri Lanka)
Hard to understand 
culture different to your 
own
“I consider myself Western, in my cultural perspective whatever that means …I would 
say that I recognize that people have different attitudes and different cultures and I 
guess one of the difficulties I have is that although we like to be what you might call 
‘culturally sensitive’ it is it is awkward to have to deal with multiple different cultures‑that 
is, exactly what one particular culture wants versus another” (Jordan, Australia)
Own culture may 
influence attitudes
“….Middle class educated Western background so. I have those sort of values of. you 
know at least in theory um. full and open kind of disclosure and discussion and…kind 
of a shared decision‑making model for the treatment options. so you know I think that’s 
probably pretty, you know, pretty profound influence” (Tom, UK)
Integrate experience of 
other cultures as part of 
own culture and attitudes
“…Once you start to recognize that there is more than one world view about how to 
communicate within the culture of the family – that can have a striking change in how 
you come to be slightly more open‑minded than before ” (Mark, Australia)
Emotional impact of 
bad news on patients, 
families and oncologists
On patient “…This is going to be a life changing event, you know, for them and for their family…… 
everything is now going to change, destroyed their family, you know, their hopes for 
future, their employment their lifestyle, everything is going to change and …it’s a very 
big thing for them” (Tariq, Iran)
On oncologist “I think all of us in oncology must develop something that we do to depersonalize that 
so that we do not get distracted every day that we come to work…” (Sylvia, UK)
Truthful disclosure is a 
gentle balancing act
Gradual disclosure “Sometimes you just need to decide how much disclosure you want to give to 
the patient on the first consult. Some patient might not be able to accept all the 
information on the on the first … you know, you might have to disclose the information 
gradually.” (Mai, China)
Discussing with the 
family first
“… Meet with the family members first to the exclusion of the patient ah and I do have a 
patient discussion with the family… I do explore with the…ah family members why they 
are wanting to protect the patient” (Stephen, Australia)
Euphemisms “I mean it depends on how bad they want the euphemism to be, if the euphemism 
is “tumor” or “serious disease” I sometimes go along with them at first. But if the 
euphemisms I’ve been asked to say they have got a bad cold I think… oh that’s just 
silly! If the euphemism is close enough for them to understand that it is serious I 
sometimes let it go for the first visit or two until I’ve got to know them better” (Bob, UK)
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thus denying patients their “natural right” to make their own 
treatment decisions.
However, most Western (6) and two non‑Western‑born (2) 
oncologists also acknowledged the importance of respecting 
the family’s wishes. Thus, they felt caught in a moral dilemma 
between respecting family wishes and ensuring patient 
autonomy. These oncologists observed that there was “art” 
in how they tackled this dilemma, which included being 
empathic, reassuring, inclusive yet firm when explaining 
to nondisclosing families the need for disclosing necessary 
information to patients.
A small number of oncologists (Western = 3, non‑Western = 2) 
felt their duty was towards the patient and not the family, 
since it was the patient who was receiving their treatment. 
These oncologists felt that nondisclosure to any degree was 
an act of deception they strongly opposed. Therefore, they 
confronted the family by telling them they would not partake 
in any dishonesty surrounding diagnosis disclosure. This 
attitude toward nondisclosure was supported by the belief 
that patients already knew they had cancer by virtue of the 
name of the cancer center, having seen previous oncologists or 
having gone through a long treatment or diagnostic process. 
Patient’s awareness was deduced by the oncologist either by 
observing the patients’ body language or by simply asking 
prompting questions such as, “What do you understand about 
what the tests have shown?” (James).
High costs of nondisclosure
Five Western and one non‑Western oncologists reported 
that the costs of the nondisclosure are multipronged and 
high. The most common concern was the potential impact of 
constrained family communication on the patient, due to their 
inability to freely discuss the disease leading to “unrealistic 
expectations,” “unanswered questions” and patients being 
unable to express their fears. Unfulfilled communication 
was viewed as especially problematical at the end of life, 
as patients were not given the chance to put their affairs in 
order and “communicate with the important people in their 
life.” This sense of unfulfilled communication was heightened 
when families used various strategies to request nondisclosure 
even before the oncologist met the patient, ranging from 
calling in advance, speaking in English if the patient was 
not English‑speaking, to leaving the oncologist a note or 
message, or “catching” or “ambushing” the oncologist in the 
hospital corridor before they entered the consulting room. 
One oncologist, Joe, reported that nondisclosure resulted 
in a personal and “lingering” sense of regret that he could 
have done things better. Indeed, oncologists Stan and Jordan 
observed that another cost of nondisclosure was inferior 
supportive and potentially medical care for the patient.
Cultural influences on interpretation and understanding of 
requests for nondisclosure
Oncologists (Western = 4, non‑Western = 4) reported that 
nondisclosure was more commonly requested by families from 
collectivist/family‑centered cultures such as Chinese, Korean, 
Greek, Italian, Arabian than those from Western cultures such 
as Australian, UK, US.
All non‑Western oncologists reported that their own culture 
helped them to understand cancer nondisclosure, while all 
Western oncologists reported that they found it difficult to 
understand cultures different from their own. Non‑Western 
oncologists felt they could be more sensitive to patients from a 
similar background at the outset, choosing a more “nondirect” 
communication style and being “cautious” in their use of the 
word “cancer”. They also felt they better understood and 
could more easily accommodate the family‑centered approach 
to medical decision‑making. However, due to their medical 
training in the Western system, they still maintained a positive 
attitude towards full disclosure.
On the other hand, Western oncologists reported that they 
struggled with understanding a “different way of thinking,” 
feeling “affronted” by nondisclosure. Western oncologists 
also felt “uncertain” about how to interpret nonverbal 
cues (e.g. smiles, gestures) as each culture might have a 
different meaning for these. Four Western oncologists noted 
that their “dominant, middle class, educated” background 
that followed a “strong medical legal flavor, which is about 
Table 3: Participant details
Name Age Gender Specialty Country 
of birth
Country of parents’ birth Country where medical 
education was completed
Joe 42 Male Medical oncology Australia Greece Australia
Jordan 39 Male Medical oncology Australia Borneo (father) and Australia (mother) Australia
Mark 57 Male Medical oncology Australia Poland Australia, UK and USA
Stan 44 Male Surgical oncology Australia Australia Australia
Stephen 34 Male Medical oncology Australia Australia Australia
Sylvia 51 Female Medical oncology UK UK (father) and Canada (mother) UK and Australia
James 42 Male Medical oncology UK UK Australia
Tom 49 Male Medical oncology UK UK (father) and Australia (mother) Australia
Bob 56 Male Radiation oncology UK UK UK and Australia
Tariq 42 Male Medical oncology Iran Iran Tehran ad Australia
Surya 53 Male Radiation oncology Sri Lanka Sri Lanka Sri Lanka
Chung 41 Male Medical oncology Hong Kong China Australia
Mai 36 Female Medical oncology China China China and Australia
Chris 34 Male Medical oncology Malaysia Malaysia (father) and Singapore (mother) Australia
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giving people information, making sure that they’ve got the 
choices” (James), had a “profound influence” on their attitude 
toward nondisclosure. However, they also felt that they had 
to “adapt” their style of communication to suit the patient’s 
background by choosing “culturally sensitive language” and 
diverse ways to share medical information. A few Western 
oncologists (Mark, Stan and Tom) consciously tried to be more 
open to and respectful of a “different world view”.
Emotional impact of bad news on patients, families and 
oncologists
Some oncologists (Western = 2, non‑Western = 2) noted that 
breaking bad news can have an emotional impact not only 
on patients, families but also oncologists. They understood 
that a cancer diagnosis has the potential to permanently 
change a person’s and their families’ life in many dimensions 
such as their occupation, lifestyle, dreams and hopes. These 
oncologists viewed emotional support as an integral part of 
their role. This was achieved by being attentive to patients’ 
emotional needs, listening to and being “tuned into” their 
“emotional requests” and normalizing their responses. 
This required oncologists to guide patients through this 
emotional journey, while assisting families to overcome 
their personal fears and anxieties in order to care for their 
ailing patient.
Three oncologists, Sylvia, Stan and Surya, felt their personal 
experience of losing their parent to cancer sensitized them 
to the “receiving end” of bad news, better equipping them to 
provide support. Indeed, all four oncologists admitted that a 
cancer diagnosis disclosure had an emotional impact on them 
as well, making breaking bad news “quite hard”. They reported 
that coping by “depersonalizing” and distancing themselves 
protected them from getting “distracted” during work, a skill 
which came with time and exposure to breaking bad news.
Truthful disclosure as a gentle balancing act
All oncologists agreed that cancer disclosure should be 
approached within a growing relationship in a gradual and 
“systematic” manner where patients had the opportunity to 
steer the communication. This step‑by‑step approach was 
described as an “art,” which aimed at ensuring patients and 
families feel secure and reassured. Consequently, oncologists 
observed, disclosure took place slowly over several meetings, 
wherein they gauged patients’ and families’ levels of 
acceptance of the information that was discussed in each 
meeting. First understanding families’ concerns regarding 
truthful disclosure and then empathically convincing the 
family about the benefits of disclosure was preferred by most 
oncologists (Western = 5, non‑Western = 4). Giving families 
the time to share their reasons for nondisclosure helped 
oncologists to understand their knowledge and perspective. 
This allowed oncologists to customize their explanations or 
“appeals” for the need for disclosure in a way that addressed 
these concerns whilst describing their own ethical obligation 
to the patient.
Further, a small group of oncologists were also inclined to 
consult families about their disclosure plan; discussing how 
and to what extent they should break the news, how the 
patient would receive news, and how they as a family could 
offer support at the time of cancer disclosure. The driving 
force for this approach was the oncologist’s desire to develop 
a “very good relationship” between all parties, by ensuring 
clarity in cancer communication and “keeping the peace” 
between family and patient. These oncologists believed there 
was no one way to break the bad news to patients, instead 
being sensitive and building patient trust was a key feature 
of being honest. This meant they had to gently balance open 
communication (with the help of the family), such that they 
were neither “sugar‑coating” vital medical information, nor 
“shocking” the patient with too much information.
Appreciating the cultural connotation of the word “cancer” 
played a key role in the way bad news was broken to patients. 
Almost all (Western = 7, non‑Western = 4) oncologists were 
not opposed to using euphemisms, as long as the patient 
was able to understand its implications. Using words such as 
“tumor,” “growth” or “lump” was most favored by oncologists 
as an acceptable approach to communicate “what’s going 
on” to patients, without threatening them or their families. 
However, although they did arrive at this compromise in 
consultation with the family, oncologists clarified that the 
choice of euphemism had to be a “close enough” description 
of the seriousness of the real disease. Sometimes, this meant 
they had to eventually find a way to use the word “cancer” in 
their consultations. Only two oncologists (Jordan and Tariq) 
disagreed with this approach as they believed that by “diluting 
the message” they were, in effect, lying to the patient.
DISCUSSION
The current study explored differences between Western and 
non‑Western‑born oncologists in the way they interpreted and 
dealt with the family request for nondisclosure in Australia. 
The findings revealed that oncologists reported family and 
language were barriers to truthful communication, the family 
request for nondisclosure posed an ethical and moral dilemma 
to them, oncologists felt there were high costs of nondisclosure 
to patients and their families, they agreed that there were 
cultural influences on interpretation and understanding of 
requests for nondisclosure, they observed an emotional impact 
of bad news on patients, families and oncologists, and they 
believed that truthful disclosure was a gentle balancing act.
The study highlighted that oncologists experienced a 
tug‑of‑war between their desire to be culturally sensitive and 
their Western medical ethics. They accommodated the central 
role of families in patients’ lives by using euphemisms, eliciting 
the family’s fears of disclosure, focusing on family comfort, 
and by a willingness to consult with the family on how to 
break the news. However, oncologists also did not want to 
disregard their medical ethics. For example, some were willing 
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to use a euphemism for “cancer,” but only if it did not stray far 
from the truth, thereby misleading the patient. Consequently, 
oncologists felt caught in a moral and ethical dilemma, as they 
struggled to balance their Western need to promote patient 
autonomy and informed consent with their recognition of the 
importance of respecting and accommodating family wishes.
The study findings highlight a need for embedding 
doctor‑patient communication within cultural sensitivity 
training,[14,15] especially in a multicultural society such 
as Australia and when disclosing bad news.[16] Building 
on the results of this study, cultural sensitivity training 
might emphasize including and engaging the family 
in communication and decision‑making,[16‑18] nonverbal 
communication, indirect speech, the cultural connotations of 
specific words and sentences, taking cues and tailoring the 
consultation based on family and patient reactions, allowing 
the patient to steer the conversation, and asking the patient 
what they would like to know. Overall, all oncologists in the 
current study felt that the optimal culturally sensitive form of 
disclosure is the gradual, step‑by‑step, consultative approach, 
which is probably optimal for all cultures.[19,20]
A unique and key finding in this study was that 
non‑Western‑born oncologists felt better equipped to 
understand and communicate with both families and patients. 
Perhaps, these oncologists can provide the necessary bridge 
between the need to adhere to Western medical ethics 
and the desire to respect the cultural contexts of cancer 
communication. Hence, it may be important to include 
non‑Western‑born oncologists when developing and delivering 
cultural sensitivity training programs.
In this study, oncologists felt nondisclosure carried high costs 
for the patient and family, who may receive sub‑optimal 
supportive and medical care and be robbed of the chance 
to finalize affairs and say their goodbyes. Previous research 
has reported a relationship between nondisclosure and 
negative patient outcomes (e.g. increased distress, unfulfilled 
communication, hopelessness),[21‑24] the avoidance of which 
were, interestingly, some of the reasons for nondisclosure 
for some Eastern families.[25‑28] Further, oncologists reported 
feeling themselves, a sense of lost opportunity and poor 
communication due to nondisclosure, suggesting that cultural 
training could improve their own outcomes. Further, it may 
be beneficial to include health psychologists/counselors in 
the communication process to facilitate culturally empathic 
communication between patients, families and physicians.
This study has several strengths and limitations that should 
be taken into account when interpreting the findings. Its 
strengths include the inclusion of oncologists who were 
and were not born in Australia, bringing different cultural 
perspectives to the question of nondisclosure, and highlighting 
the contribution that nonnative‑born health professionals can 
make to this discourse. While an in‑depth qualitative approach 
was appropriate in gaining the perspectives of oncologists, 
and the data reached saturation suggesting that all relevant 
themes had been elicited, the results may not be generalizable 
to the wider oncology population, and quantitative research 
to build on this study would be helpful.
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